Summary
Toxicities associated with immunomodulatory drugs are often not detected during non-clinical development. This is because existing non-clinical animal and cellular models do not adequately represent the complexity of the of immune system. The imSAVAR objectives are:- To...
More information & hyperlinks
Web resources: | https://imsavar.eu/ |